#BEGIN_DRUGCARD DB04267

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
46837

# Chemical_Formula:
C7H5NO4

# Chemical_IUPAC_Name:
pyridine-2,6-dicarboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Chelating Agents
Enzyme Inhibitors

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Dipicolinic Acid

# HET_ID:
PDC

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-5(8-4)7(11)12/h1-3H,(H,9,10)(H,11,12)

# InChI_Key:
InChIKey=WJJMNDUMQPNECX-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4267

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
167.1189

# Molecular_Weight_Mono:
167.021857653

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1ARZ

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.54

# Predicted_LogS:
-1.7

# Predicted_Water_Solubility:
3.46e+00 g/l

# Primary_Accession_No:
DB04267

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
10367

# PubChem_Substance_ID:
46505713

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02530

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)C1=CC=CC(=N1)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:09 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M10611

# Drug_Target_1_GenBank_ID_Protein:
145710

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
dapB

# Drug_Target_1_Gene_Sequence:
>822 bp
ATGCATGATGCAAACATCCGCGTTGCCATCGCGGGAGCCGGGGGGCGTATGGGCCGCCAG
TTGATTCAGGCGGCGCTGGCATTAGAGGGCGTGCAGTTGGGCGCTGCGCTGGAGCGTGAA
GGATCTTCTTTACTGGGCAGCGACGCCGGTGAGCTGGCCGGAGCCGGGAAAACAGGCGTT
ACCGTGCAAAGCAGCCTCGATGCGGTAAAAGATGATTTTGATGTGTTTATCGATTTTACC
CGTCCGGAAGGTACGCTGAACCATCTCGCTTTTTGTCGCCAGCATGGCAAAGGGATGGTG
ATCGGCACTACGGGGTTTGACGAAGCCGGTAAACAAGCAATTCGTGACGCCGCTGCCGAT
ATTGCGATTGTCTTTGCGGCCAATTTTAGCGTTGGCGTTAACGTCATGCTTAAGCTGCTG
GAGAAAGCAGCCAAAGTGATGGGTGACTACACCGATATCGAAATTATTGAAGCACATCAT
AGACATAAAGTTGATGCGCCGTCAGGCACCGCACTGGCAATGGGAGAGGCGATCGCCCAC
GCCCTTGATAAAGATCTGAAAGATTGCGCGGTCTACAGTCGTGAAGGCCACACCGGTGAA
CGTGTGCCTGGCACCATTGGTTTTGCCACCGTGCGTGCAGGTGACATCGTTGGTGAACAT
ACCGCGATGTTTGCCGATATTGGCGAGCGTCTGGAGATCACCCATAAGGCGTCCAGCCGT
ATGACATTTGCTAACGGCGCGGTAAGATCGGCTTTGTGGTTGAGTGGTAAGGAAAGCGGT
CTTTTTGATATGCGAGATGTACTTGATCTCAATAATTTGTAA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
1630901	Yura T, Mori H, Nagai H, Nagata T, Ishihama A, Fujita N, Isono K, Mizobuchi K, Nakata A: Systematic sequencing of the Escherichia coli genome: analysis of the 0-2.4 min region. Nucleic Acids Res. 1992 Jul 11;20(13):3305-8.
6094578	Bouvier J, Richaud C, Richaud F, Patte JC, Stragier P: Nucleotide sequence and expression of the Escherichia coli dapB gene. J Biol Chem. 1984 Dec 10;259(23):14829-34.
6377309	Bouvier J, Patte JC, Stragier P: Multiple regulatory signals in the control region of the Escherichia coli carAB operon. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4139-43.
7893645	Scapin G, Blanchard JS, Sacchettini JC: Three-dimensional structure of Escherichia coli dihydrodipicolinate reductase. Biochemistry. 1995 Mar 21;34(11):3502-12.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9398235	Scapin G, Reddy SG, Zheng R, Blanchard JS: Three-dimensional structure of Escherichia coli dihydrodipicolinate reductase in complex with NADH and the inhibitor 2,6-pyridinedicarboxylate. Biochemistry. 1997 Dec 9;36(49):15081-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3618

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
28757

# Drug_Target_1_Name:
Dihydrodipicolinate reductase

# Drug_Target_1_Number_of_Residues:
273

# Drug_Target_1_PDB_ID:
1DRW

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01113	DapB_N
PF05173	DapB_C

# Drug_Target_1_Protein_Sequence:
>Dihydrodipicolinate reductase
MHDANIRVAIAGAGGRMGRQLIQAALALEGVQLGAALEREGSSLLGSDAGELAGAGKTGV
TVQSSLDAVKDDFDVFIDFTRPEGTLNHLAFCRQHGKGMVIGTTGFDEAGKQAIRDAAAD
IAIVFAANFSVGVNVMLKLLEKAAKVMGDYTDIEIIEAHHRHKVDAPSGTALAMGEAIAH
ALDKDLKDCAVYSREGHTGERVPGTIGFATVRAGDIVGEHTAMFADIGERLEITHKASSR
MTFANGAVRSALWLSGKESGLFDMRDVLDLNNL

# Drug_Target_1_Reaction:
(S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + NAD(P)+ = 2,3-dihydrodipicolinate + NAD(P)H + H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
2,3,4,5-tetrahydrodipicolinate + NAD(P)(+) = 2,3-dihydrodipicolinate + NAD(P)H

# Drug_Target_1_SwissProt_ID:
P04036

# Drug_Target_1_SwissProt_Name:
DAPB_ECOLI

# Drug_Target_1_Synonyms:
DHPR
EC 1.3.1.26

# Drug_Target_1_Theoretical_pI:
5.55

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
U66101

# Drug_Target_2_GenBank_ID_Protein:
1513224

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
dapB

# Drug_Target_2_Gene_Sequence:
>738 bp
ATGCGGGTAGGCGTCCTTGGAGCCAAAGGCAAGGTCGGAACGACAATGGTGCGGGCGGTG
GCCGCCGCCGACGACCTGACCCTATCCGCCGAGCTGGATGCCGGCGATCCGCTGAGCCTG
CTAACGGACGGTAACACCGAGGTCGTCATCGACTTCACCCACCCGGACGTGGTGATGGGC
AATCTGGAGTTCCTCATCGACAACGGAATTCACGCCGTGGTCGGTACCACGGGGTTCACC
GCCGAGCGGTTTCAACAAGTCGAATCGTGGCTCGTCGCAAAACCCAACACATCGGTGTTG
ATAGCGCCAAACTTCGCGATCGGAGCGGTGCTGTCCATGCATTTCGCCAAGCAGGCCGCA
CGGTTTTTCGACTCGGCCGAGGTCATTGAGCTGCATCATCCGCACAAGGCTGACGCGCCG
TCAGGCACGGCCGCGCGTACCGCGAAGCTGATCGCCGAGGCCCGAAAAGGCTTGCCGCCC
AATCCCGATGCCACCAGTACCAGCCTGCCGGGCGCGCGTGGTGCCGACGTCGACGGCATA
CCGGTGCACGCGGTGCGGCTGGCCGGACTGGTCGCCCACCAGGAAGTGCTGTTCGGGACC
GAGGGGGAGACTCTGACCATCCGCCACGATAGCCTCGATCGCACATCGTTTGTGCCCGGT
GTGCTGTTGGCGGTGCGCCGCATCGCCGAACGCCCTGGTCTCACCGTAGGTCTTGAGCCC
CTACTCGATCTGCACTGA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9098082	Pavelka MS Jr, Weisbrod TR, Jacobs WR Jr: Cloning of the dapB gene, encoding dihydrodipicolinate reductase, from Mycobacterium tuberculosis. J Bacteriol. 1997 Apr;179(8):2777-82.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3615

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
25734

# Drug_Target_2_Name:
Dihydrodipicolinate reductase

# Drug_Target_2_Number_of_Residues:
245

# Drug_Target_2_PDB_ID:
1P9L

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01113	DapB_N
PF05173	DapB_C

# Drug_Target_2_Protein_Sequence:
>Dihydrodipicolinate reductase
MRVGVLGAKGKVGATMVRAVAAADDLTLSAELDAGDPLSLLTDGNTEVVIDFTHPDVVMG
NLEFLIDNGIHAVVGTTGFTAERFQQVESWLVAKPNTSVLIAPNFAIGAVLSMHFAKQAA
RFFDSAEVIELHHPHKADAPSGTAARTAKLIAEARKGLPPNPDATSTSLPGARGADVDGI
PVHAVRLAGLVAHQEVLFGTEGETLTIRHDSLDRTSFVPGVLLAVRRIAERPGLTVGLEP
LLDLH

# Drug_Target_2_Reaction:
(S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + NAD(P)+ = 2,3-dihydrodipicolinate + NAD(P)H + H+

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
2,3,4,5-tetrahydrodipicolinate + NAD(P)(+) = 2,3-dihydrodipicolinate + NAD(P)H

# Drug_Target_2_SwissProt_ID:
P72024

# Drug_Target_2_SwissProt_Name:
DAPB_MYCTU

# Drug_Target_2_Synonyms:
DHPR
EC 1.3.1.26

# Drug_Target_2_Theoretical_pI:
5.75

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04267
